Patterns of peri-operative systemic therapy in liver-limited metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Kellock, Trenton Tyler [1 ]
Renouf, Daniel John [1 ]
Speers, Caroline [1 ]
Cheung, Winson Y. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Population-based patterns of systemic therapy use in liver-limited metastatic colorectal cancer (mCRC)
    Kellock, Trenton Tyler
    Gresham, Gillian
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [2] Treatment of Liver-Limited Metastatic Colorectal Cancer
    Hubbard, Joleen M.
    Alberts, Steven R.
    CANCER JOURNAL, 2010, 16 (03): : 235 - 240
  • [3] Updated Options for Liver-Limited Metastatic Colorectal Cancer
    Alberts, Steven R.
    CLINICAL COLORECTAL CANCER, 2008, 7 : S58 - S62
  • [4] Treatment Advances in Liver-Limited Metastatic Colorectal Cancer
    Alberts, Steven R.
    Poston, Graeme J.
    CLINICAL COLORECTAL CANCER, 2011, 10 (04) : 258 - 265
  • [5] Regional chemotherapy for liver-limited metastatic colorectal cancer
    Power, Derek G.
    Healey-Bird, Brian R.
    Kemeny, Nancy E.
    CLINICAL COLORECTAL CANCER, 2008, 7 (04) : 247 - 259
  • [6] American medical oncology physician (AMOP) preferences for combined modality therapy beginning with systemic management in patients with liver-limited metastatic colorectal cancer (LL-mCRC)
    Choti, Michael A.
    Green, Mark R.
    Corral, Mitra
    Wong, Schiffon L.
    Cairns, Jessica
    Thomas, Michele R.
    Eaddy, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] Peri-operative chemotherapy for resectable colorectal liver metastasis: Does timing of systemic therapy matter?
    Marques, Hugo Pinto
    Barroso, Eduardo
    De Jong, Mechteld C.
    Choti, Michael A.
    Ribeiro, Vasco
    Nobre, Ana Marta
    Carvalho, Carlos
    Pawlik, Timothy M.
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (06) : 511 - 519
  • [8] Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC)
    Ongaro, E.
    Rossini, D.
    Pietrantonio, F.
    Morano, F.
    de Braud, F.
    Mazzaferro, V.
    Corti, F.
    Randon, G.
    Raimondi, A.
    Battaglia, L.
    Morelli, L.
    Urbani, L.
    Masi, G.
    Moretto, R.
    Antoniotti, C.
    Marmorino, F.
    Borelli, B.
    Zucchelli, G.
    Boccaccino, A.
    Cremolini, C.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Improving Response and Outcomes for Patients With Liver-Limited Metastatic Colorectal Cancer
    Gallagher, David J.
    Kemeny, Nancy
    CLINICAL COLORECTAL CANCER, 2010, 9 : S36 - S43
  • [10] Decision Making Around Optimal Management of Liver-Limited Metastatic Colorectal Cancer
    Robert P. Jones
    Graeme J. Poston
    Annals of Surgical Oncology, 2016, 23 : 353 - 354
12345